This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Katakami, N. et al. Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04). Cancer http://dx.doi.org/10.1002/cncr.31128 (2017)
Rights and permissions
About this article
Cite this article
Sidaway, P. Anamorelin provides benefit to patients with cachexia. Nat Rev Clin Oncol 15, 68 (2018). https://doi.org/10.1038/nrclinonc.2017.204
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2017.204